Machine learning algorithms to predict the risk of admission to intensive care units in HIV-infected individuals: a single-centre study

利用机器学习算法预测艾滋病毒感染者入住重症监护室的风险:一项单中心研究

阅读:4

Abstract

Antiretroviral therapy (ART) has transformed HIV from a rapidly progressive and fatal disease to a chronic disease with limited impact on life expectancy. However, people living with HIV(PLWHs) faced high critical illness risk due to the increased prevalence of various comorbidities and are admitted to the Intensive Care Unit(ICU). This study aimed to use machine learning to predict ICU admission risk in PLWHs. 1530 HIV patients (199 admitted to ICU) from Beijing Ditan Hospital, Capital Medical University were enrolled in the study. Classification models were built based on logistic regression(LOG), random forest (RF), k-nearest neighbor (KNN), support vector machine (SVM), artificial neural network(ANN), and extreme gradient boosting(XGB). The risk of ICU admission was predicted using the Brier score, area under the receiver operating characteristic curve (ROC-AUC), and area under the precision-recall curve(PR-ROC) for internal validation and ranked by Shapley plot. The ANN model performed best in internal validation (Brier score = 0.034, ROC-AUC = 0.961, PR-AUC = 0.895) to predict the risk of ICU admission for PLWHs. 11 important features were identified to predict predict ICU admission risk by the Shapley plot: respiratory failure, multiple opportunistic infections in the respiratory system, AIDS defining cancers, baseline viral load, PCP, baseline CD4 cell count, and unexplained infections. An intelligent healthcare prediction system could be developed based on the medical records of PLWHs, and the ANN model performed best in effectively predicting the risk of ICU admission, which helped physicians make timely clinical interventions, alleviate patients suffering, and reduce healthcare cost.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。